The role of18F-FDG PET/CT in the evaluation of ascites of undetermined origin

Journal of Nuclear Medicine

Volumn 50, Issue 4, 2009, Pages 506-512

  Zhang, Miao ^a   Jiang, Xufeng ^a   Zhang, Min ^a   Xu, Haoping ^a   Zhai, Ge ^a   Li, Biao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

18F FDG PET CT; ascites; cavum abdominis metastases tuberculosis

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BENIGN TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; DRUG UPTAKE; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER CANCER; LIVER CIRRHOSIS; LUNG CANCER; MALE; MESOTHELIOMA; OVARY CANCER; PANCREAS CANCER; PERITONEAL CAVITY; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TUBERCULOUS PERITONITIS; TUMOR VOLUME; CLASSIFICATION; EVALUATION; IMAGE ENHANCEMENT; IMAGE SUBTRACTION; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 63849230523     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.056382     Document Type: Article

References (22)

1. Greco AV, Mingrone G, Gasbarrini G. Free fatty acid analysis in ascitic fluid improves diagnosis in malignant abdominal tumors. Clin Chim Acta. 1995;239:13-22.
2. McHutchison JG. Differential diagnosis of ascites. Semin Liver Dis. 1997; 17:191-202.
3. Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol. 2007;18:945-949.
4. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358-363.
5. Porcel A, Alcaín G, Moreno M, Amaya A, Guillen P, Martin L. Value of laparoscopy in ascites of undetermined origin. Rev Esp Enferm Dig. 1996;88:485-489.
6. Boudiaf M, Bedda S, Soyer P, et al. Preoperative evaluation of gastric adenocarcinomas: comparison of CT results with surgical and pathologic results. Ann Chir. 1999;53:115-122.
7. Low RN, Barone RM, Lacey C, Sigeti JS, Alzate GD, Sebrechts CP. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology. 1997;204:513-520.
8. Kolesnikov-Gauthier H, Levy E, Merlet P, et al. FDG PET in patients with cancer of an unknown primary. Nucl Med Commun. 2005;26:1059-1066.
9. Bohuslavizki KH, Klutmann S, Kroger S, et al. FDG PET detection of unknown primary tumors. J Nucl Med. 2000;41:816-822.
10. 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med. 2003;44:1301-1314.
11. 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med. 2003;44:690-699.
12. Suzuki A, Kawano T, Takahashi N, et al. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl MedMol Imaging. 2004;31:1413-1420.
13. 18F-FDG PET. J Nucl Med. 2003;44:1407-1412.
14. 18F-FDG PET of colon polyps: potential technique for selective detection of cancer and precancerous lesions. AJR. 2007;188:130-138.
15. Berger KL, Nichokson SA, Dehdashi F, Siegel BA. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR. 2000;74:1005-1008.
16. Liu IJ, Zafar MB, Lai YH, Segall GM, Terris MK. Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology. 2001;57:108-111.
17. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm indiameter, with special reference to the CT images. Lung Cancer. 2004;45:19-27.
18. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35-45.
19. 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med. 2004;45:695-700.
20. Koc S, Beydilli G, Tulunay G, et al. Peritoneal tuberculosis mimicking advanced ovarian cancer: a retrospective review of 22 cases. Gynecol Oncol. 2006;103: 565-569.
21. Penna L, Manyonda I, Amias A. Intra-abdominal miliary tuberculosis presenting as disseminated ovarian carcinoma with ascites and raised CA125. Br J Obstet Gynaecol. 1993;100:1051-1053.
22. Jeffry L, Kerrou K, Camatte S, et al. Peritoneal tuberculosis revealed by carcinomatosis on CT scan and uptake at FDG-PET. Br J Obstet Gynecol. 2003;110:1129-1131.